Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate.

Slides:



Advertisements
Similar presentations
Copyright (c) 2004 Elsevier Inc. All rights reserved. Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics Chapter.
Advertisements

PERSECTIVES ON OPIOID TREATMENT OF CHRONIC PAIN Jane C Ballantyne MD FRCA University of Washington School of Medicine Seattle, WA USA.
OPIOIDS I. Where do they come from? / synthesized in 1803
ACUTE CANCER PAIN Dr Mike Bennett Senior Clinical Lecturer in Palliative Medicine St Gemma’s Hospice and University of Leeds.
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Opioids in Chronic Pain Management o Benefits and Risks o Side effects: constipation, sleep disruption, altered mental status, itching, nausea, respiratory.
Opioid Induced Neurotoxicity
Sublingual Buprenorphine and Pain
2008. Diagnostic criteria  At least 10 episodes fulfilling following criteria  Headache lasting 30 mins to 7 days  Has 2 at least 2 of the following.
Pain Management in the “Difficult Patient”
Opioids & Sedatives Toxicity
Chapter 42 Pain.
Jay S Grider DO/PhD Division Chief, Pain Medicine and Regional Anesthesia Medical Director, UKHealthCare Pain Services Associate Professor, Department.
Opioid Induced Hyperalgesia
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
4th Annual Thoughtful Pain Management
Pethidine: Gap Between Evidence and Practice Professor Richard Day Dept of Clinical Pharmacology and Toxicology St Vincent’s Hospital, Sydney Prepared.
Pain Management for Patients in OTPs. Pain Prevalence Study of (2) populations 1 –(390) pts in MMT –(531) pts in short term residential –Prevalence of.
Buprenorphine for Pain and for Addiction David A. Moltz, MD MAPP Clinical Conference April 30, 2010.
Biology of Substance Abuse
Buprenorphine for Pain and for Addiction David A. Moltz, MD MAPP Clinical Conference April 30, 2010.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Pain Most common reason people seek health care Tissue damage activates free nerve endings (pain receptors) Generally indicates tissue damage.
Alcohol and Other Drugs
OPIOIDS I. Where do they come from? –poppy plant: from middle east and Asia –dried sap from plant is opium; cultivated annually BUT plant produces drug.
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
By: Jessica Jeffries.  Isolated from Opium (agonist)  Metabolized to morphine (elicit analgesia)  Used to replace morphine (not thought to be addictive)
By: Dr. safa bakr M.B.Ch.B. ,H.D.A. ,F.I.B.M S.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Opioid Induced Hyperalgesia Walter Ling MD Integrated Substance Abuse Programs UCLA APA annual meeting New York NY May 3, 2004.
Allegheny County Overdose Prevention Coalition
Opioid Tolerance and Opioid- Induced Hyperalgesia David J. Clark.
Unit 3 – Neurobiology and Communication
Pain II: Cancer Pain Management Dr. Leah Steinberg.
A Revolution in Pain Pharmaceuticals 1. The Problem Opioids are the oldest and most prescribed pain drugs. They are the most powerful analgesics for treatment.
Buprenorphine {Suboxone®, Subutex®}
UCLA Brain Institute Outreach Adrina Kocharian and Rachel Oseas.
Mansour Choubsaz MD Kums.ac.ir. chronic postsurgical pain (CPSP), Approximately 40 million surgical procedures take place across North America each year.
Addiction vs. Physical Dependence Katie Ulrich Clinical Psychologist.
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
Medication Assisted Treatment Daniel T. Brown, D.O. Medical Director, Meridian HealthCare.
Do not agonize any kind of pain, take Ultram Tramadol.
Gregory S. Brigham, Ph.D., CEO
What Our Patients Look Like
List Three Mechanisms by which Chronic Opioid Therapy Can Worsen Pain
Buprenorphine for Pain and for Addiction
What does pharmacology have to do with treatment of heroin addiction?
Clinical Opiate Withdrawal – Symptom Management Protocol
Opioids for the management chronic non-cancer pain in Primary Care:
Opioids for chronic non-cancer pain? Which ones.....if any?
Opiate   A drug derived from alkaloids of the opium poppy Opioid  The class of drugs that includes opiates, opiopeptins, and all synthetic.
Acute Pain Management for Patients Receiving Buprenorphine Therapy
Ketamine analgesia CLINICAL REPORTS
Pain Management: Patients Maintained on Buprenorphine
Drug antagonism Lab 7 Dr. Raz Mohammed
Neurobiology of Addiction: The Gain in the Brain is in the Pain
NMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance  Donald D Price, PhD, David J Mayer, PhD, Jianren Mao,
School of Pharmacy, University of Nizwa
School of Pharmacy, University of Nizwa
Opioids & Sedatives Toxicity
ADDICTION
Pain management (part 2)
Medications used in Treatment of Alcohol and Drug Use Disorders
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Presentation transcript:

Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate Dean School of Nursing and Health Studies Georgetown University

“For pain is perhaps but a violent pleasure? Who could determine the point where pleasure becomes pain, where pain is still a pleasure? –Honoré De Balzac (1799–1850) “Pleasure and pain, though directly opposite, are yet so contrived by nature as to be constant companions; and it is a fact that the same motions and muscles of the face are employed both laughing and crying. Pierre Charron ( ) Pain Pleasure A Continuum of Sensation

Becerra L. et al. Neuron. 2001;32(5): Neuro-anatomical overlap of pain and reward

Effects can be blocked with naloxone Binding induces second-messenger induced changes Opioid systems in underlie both Pain and Reward responses Ballantyne and LaForge, 2007

1 Elmer, et al Elmer, et al Oliverio, et al Semenova, et al Elmer, et al Olivero & Castellano Brase, et al Gwynn & Domino Mogil, et al Belknap, et al Berrettini, et al Mogil, et al Petruzzi, et al. 1997, 14 Gelernter, et al Opioid Responses by Murine Strain

Pain Tolerance in Opioid and Cocaine abusers (Compton, 1994)

Pain tolerance by  -opioid agonist activity (n = 18/group) Length of cold-pressor immersion (min) Compton, P et al., Drug Alcohol Depend 2001; 63:

“At such times I have certainly felt it a great responsibility to say that pain, which I know is an evil, is less injurious than morphia, which may be an evil. Here experience is needed. Does morphia tend to encourage the very pain it pretends to relieve?” “ On the abuse of hypodermic injections of morphia,” Clifford Albutt, Practitioner 1870; 3: “He is also affected by a hypersensitiveness to pain, or a morbid intolerance of any kind of distress …. He suffers. His suffering is actually great. To his astigmatic inner eye it seems even greater than it is.” “What is the morphine disease?” Charles W. Carter Journal of Inebriety 1908;30: Not a new observation

Opioid-induced Hyperalgesia  Increased sensitivity to pain resulting from opiate administration  Pain-free murine models made tolerant to morphine have significantly decreased tolerance of pain Opioids, in addition to providing analgesia, set in motion anti-analgesic or hyperalgesic processes  Opioid-withdrawal hyperalgesia as an “unmasking” of underlying opioid-induced hyperalgesic state

OIH in animal models Detectable during opioid analgesia Dose-dependent Increases with repeated withdrawal episodes Intensifies with antagonist precipitated withdrawal Gender differences Can be detected within hours of opioid administration Li X, et al., Brain Res Mol Brain Res 2001;86:56-62.

Opioid Responses by Murine Strain Liang DY, et al., Pharmacogenet Genomics. 2006;16(11): C57BL/6J common inbred - Poor baseline pain tolerance - Poor analgesia response - High opioid reinforcement

Pain tolerance Opioid-induced analgesia Opioid-induced hyperalgesia Adapted from: Solomon R, American Psychologist 1980; 35(8): ; Koob GF, et al, Neuroscience & Biobehavioral Reviews 1989;13: Opioid-induced hyperalgesia as an Opponent Process Opioid administration

*P = **P = * ** Minutes 15 Minutes Seconds IM morphineIV morphineIV hydromorphonePlacebo Change in Cold-Pressor Pain Tolerance by Condition at 5 and 15 Minutes Compton P, et al. J Pain. 2003;4(9):

↑ cytokine, chemokine + Peripheral neuron Central neuron Maier D, et al., 2004 ; DeLeo JA, et al., 2004 Glu NMDA-R PK C + mu opioid-R + morphine Glial cell

Chronic Pain and opioid-induced hyperalgesia Across a number of case studies, the emergence of hyperalgesia and allodynia has been reported in patients with malignant and non-malignant pain Occurs large or rapidly escalating doses of morphine or fentanyl symptoms resolved with: dramatically decreasing or discontinuation of opioid switching to a weaker opioid ketamine (NMDA-antagonist) administration

Opioid-induced Hyperalgesia in Chronic Pain * Cold-pressor pain tolerance before and after one month of opioid therapy (75mg MS) in chronic pain patients (n = 6) Chu, Clark & Angst, 2006

OIH in chronic pain patients Pain associated with standard lidocaine injection is correlated with opioid dose and duration of opioid treatment Cohen S, et al., Reg Anesth Pain Med 2008; 33: VAS pain intensity Dose in morphine equivalentsDuration on opioid therapy

Chronic Pain Opioid Therapy Improved functioning Unimproved functioning Addictive disease + opioid non- responsive pain Adapted from: Weaver & Schnoll The Clinical Journal of Pain :S61-S69 Mitra Journal of Opioid Management : Psychiatric Illness Opioid-induced hyperalgesia Opioid-responsive pain Absence of addiction Opioid-responsive pain Absence of addiction

Differential Dx Nature of painOnset Response to opioid administration Type of previous opioid used Increased pain pathology Localized to pain site VariablePain improvesNeither Opioid tolerance Localized to pain site GradualPain improvesLong acting Opioid withdrawal Diffuse, hyperalgesia AbruptPain improvesShort acting Opioid-induced hyperalgesia Diffuse, hyperalgesia Abrupt or Gradual Pain worsensShort acting Pseudo- addiction Localized to pain site OngoingPain improveseither Addictive disease Diffuse, hyperalgesia OngoingPain worsensShort acting Pain Characteristics and Opioid Analgesia responses

Guidelines for clinical management of OIH Opioid sparing strategies Avoid short-acting formulations Avoid emergence of withdrawal Opioid rotation Use of adjuvant medications NMDA antagonists GABA agonists Anti-inflammatory analgesics Low dose opioid antagonists

Gaba-agonist effects on OIH No overall GPN effect on pain responses by group *p=0.02, **p =0.01 * ** * *p=0.03 However, for abstinent subjects, significant improvements in cold-pressor pain responses noted. (Compton et al., 2010)

Does pain protect patient from addiction responses? Under acute pain conditions: Significantly less morphine analgesic tolerance in pain assays Significantly less morphine physical withdrawal symptoms ( Brown et al., 2002, Vaccarino et al., 1993) Significantly less opioid reward or euphoria (Zacny et al., 1996)

Antagonist effect of pain on IL1-ra Compton et al, 2012

THANK YOU! Presenter Contact Details: Peggy Compton RN, PhD, FAAN Associate Dean and Professor School of Nursing and Health Studies Georgetown University 24